Skip to main content
medicine.duke.edu

Search form

  • About the Department
    • Leadership
    • Facts and Figures
    • Diversity, Equity, and Inclusion
    • Achievements & Recognition
    • History
    • Our Well-Being
    • Giving
    • Careers
    • Map and Directions
    • Contact Us
  • Divisions
    • Cardiology
    • Endocrinology, Metabolism, and Nutrition
    • Gastroenterology
    • General Internal Medicine
    • Geriatrics
    • Hematologic Malignancies and Cellular Therapy
    • Hematology
    • Infectious Diseases
    • Medical Oncology
    • Nephrology
    • Pulmonary, Allergy, and Critical Care Medicine
    • Rheumatology and Immunology
  • Faculty
    • Distinguished Faculty
    • Faculty Development
  • Patient Care
    • Referrals
    • In the Community
  • Research
    • Research Strategic Plan
    • Basic and Translational Research
    • Clinical Research
    • Duke Institutes and Centers
    • Research Administration
    • Research Laboratories
    • Research Resources
    • Grants and Funding
    • Publications
    • Science Culture and Accountability
  • Education and Training
    • Internal Medicine Residency
    • Fellowship Programs
    • Doctor of Medicine
    • Training Sites
    • Our Commitment to Diversity and Inclusion in Training
    • Our Trainees
    • Continuing Medical Education
    • Lefkowitz Society
    • MENTORS Program
    • Education Awards
    • About Duke and Durham
  • MedicineNews
    • News Archives
    • Submit News
    • Calendar
    • News
    • Voices of Medicine
    • Disparities research
  • About the Department
    • Leadership
    • Facts and Figures
    • Diversity, Equity, and Inclusion
    • Achievements & Recognition
    • History
    • Our Well-Being
    • Giving
    • Careers
    • Map and Directions
    • Contact Us
  • Divisions
    • Cardiology
    • Endocrinology, Metabolism, and Nutrition
    • Gastroenterology
    • General Internal Medicine
    • Geriatrics
    • Hematologic Malignancies and Cellular Therapy
    • Hematology
    • Infectious Diseases
    • Medical Oncology
    • Nephrology
    • Pulmonary, Allergy, and Critical Care Medicine
    • Rheumatology and Immunology
  • Faculty
    • Distinguished Faculty
    • Faculty Development
  • Patient Care
    • Referrals
    • In the Community
  • Research
    • Research Strategic Plan
    • Basic and Translational Research
    • Clinical Research
    • Duke Institutes and Centers
    • Research Administration
    • Research Laboratories
    • Research Resources
    • Grants and Funding
    • Publications
    • Science Culture and Accountability
  • Education and Training
    • Internal Medicine Residency
    • Fellowship Programs
    • Doctor of Medicine
    • Training Sites
    • Our Commitment to Diversity and Inclusion in Training
    • Our Trainees
    • Continuing Medical Education
    • Lefkowitz Society
    • MENTORS Program
    • Education Awards
    • About Duke and Durham
  • MedicineNews
    • News Archives
    • Submit News
    • Calendar
    • News
    • Voices of Medicine
    • Disparities research
  • Home
  • Divisions
  • Hematologic Malignancies and Cellular Therapy
  • Research
  • Clinical Research
Hematologic Malignancies and Cellular Therapy

Clinical Research

Learn About Our Clinical Trials

  • BMT and Cellular Therapies
  • Leukemia and Multiple Myeloma
  • Lymphomas - Non-Hodgkins Lymphoma and Hodgkins Lymphoma
  • About
  • Faculty
  • Patient Care
  • Education and Training
  • Research
    • Basic Research
    • Clinical Research
    • Institutes and Labs
    • Collaborate with Us
  • Division Events
  • Division News

Recent Articles

14 Medicine faculty selected for Leadership Development for Researchers (LEADER) Program
New Faculty: October 2020
Divisions select faculty recipients for 2020 Excellence in Education Awards
Call for applications: Duke UNC-Chapel Hill Immunotherapy Training Grant
13 Medicine faculty recognized by the School of Medicine

Recent publications by our faculty

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Am J Hematol
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
Bone Marrow Transplant
Early Palliative Care Services and End-of-Life Care in Medicare Beneficiaries with Hematologic Malignancies: A Population-Based Retrospective Cohort Study.
Journal of Palliative Medicine
View all our publications
medicine.duke.edu

Quick Links

  • Diversity
  • Careers
  • Giving
  • About Duke and Durham

Twitter RSS

  • medschool.duke.edu
  • duke.edu
  • dukehealth.org

Copyright 2004-2019 Duke University and Duke University Health System, All rights reserved